Yemen

in page functions
Total population (2012)25,569,263
Birth cohort (2012)958,116
Surviving Infants (surviving to 1 year per year, 2012)914,882
Infant mortality rate (deaths < 1 year per 1000 births, 2012)45.12/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012)57.77/1000
World Bank Index, IDA (2012)3.17
Gross Nation Income (per capita US$, 2009)1,070
Co-financing status (2012)Intermediate
No. of districts/territories (2009)333

GAVI support for Yemen

Type of support

Approvals

2001-2016 (US$)
(31 Dec 2011)

Commitments

2001-2016 (US$)
(31 Dec 2011)

Disbursements

2001-2012 (US$)
(31 Dec 2011)

% Disbursed

(31 Dec 2011)
200120022003200420052006200720082009201020112012201320142015
Health System Strengthening (HSS)$6,335,000$6,335,000$6,335,000100%
Immunisation Services Support (ISS)$5,049,500$5,049,500$3,840,50076%
Injection Safety Support (INS)$1,194,757$1,194,757$1,194,757100%
Penta (NVS)$53,260,033$66,541,033$49,971,89694%
Pneumo (NVS)$39,586,780$80,579,780$26,330,38867%
Rotavirus (NVS)$5,648,500$20,183,000
Vaccine Introduction Grant$727,500$727,500$727,500100%
Total$111,802,069$180,610,569$88,400,041

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding (IRC Reviewed)

Download data for commitments & disbursements in XLS format

Yemen DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2010)87%
DTP3 - Official country estimates (2010)87%
M:F sex ratio at birth (2012)1.05%
Household survey: DTP3 coverage for male (2006)61.70%
Household survey: DTP3 coverage for female (2006)60.20%
Household survey: Last DTP3 survey (2006)61%
% districts achieving > 80% DTP3 coverage (2010)10%
% districts achieving < 50% DTP3 coverage (2010)8%
MCV WHO/UNICEF estimates (2010)73%
Polio WHO/UNICEF estimates (2010)88%

Breakdown of support

CSO, HSS & ISS supportVaccine support
14% 86%
$12,097,757 $76,302,284

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Yemen

24 April 2012

rotavirus cost-effectiveness

Rotavirus vaccines, potential to save 2.4 million lives

Special supplemental issue of the journal Vaccine provides critical insights on rotavirus vaccine performance to help maximize their impact in developing countries.

10 November 2011

08-GAVI-11-Riccardo Gangale-Kenya

15 October 2011

Ethiopia pneumo launch

GAVI Alliance partners to tackle childhood killer in Ethiopia

Largest introduction to date of life-saving pneumococcal vaccines to be provided to Ethiopian children. [Français]

close icon

modal window here